- Home
- HUBS vs PODD Comparison
HUBS vs PODD Comparison
Compare HUBS & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUBS
- PODD
- Stock Information
- Founded
- HUBS 2005
- PODD 2000
- Country
- HUBS United States
- PODD United States
- Employees
- HUBS N/A
- PODD N/A
- Industry
- HUBS Computer Software: Prepackaged Software
- PODD Medical/Dental Instruments
- Sector
- HUBS Technology
- PODD Health Care
- Exchange
- HUBS Nasdaq
- PODD Nasdaq
- Market Cap
- HUBS 23.8B
- PODD 22.1B
- IPO Year
- HUBS 2014
- PODD 2007
- Fundamental
- Price
- HUBS $386.16
- PODD $321.76
- Analyst Decision
- HUBS Strong Buy
- PODD Strong Buy
- Analyst Count
- HUBS 29
- PODD 19
- Target Price
- HUBS $630.38
- PODD $346.95
- AVG Volume (30 Days)
- HUBS 829.9K
- PODD 536.4K
- Earning Date
- HUBS 11-05-2025
- PODD 11-06-2025
- Dividend Yield
- HUBS N/A
- PODD N/A
- EPS Growth
- HUBS N/A
- PODD N/A
- EPS
- HUBS N/A
- PODD 3.45
- Revenue
- HUBS $2,987,698,000.00
- PODD $2,521,800,000.00
- Revenue This Year
- HUBS $19.81
- PODD $29.32
- Revenue Next Year
- HUBS $16.20
- PODD $18.37
- P/E Ratio
- HUBS N/A
- PODD $93.51
- Revenue Growth
- HUBS 19.21
- PODD 27.11
- 52 Week Low
- HUBS $375.01
- PODD $230.05
- 52 Week High
- HUBS $881.13
- PODD $353.50
- Technical
- Relative Strength Index (RSI)
- HUBS 29.52
- PODD 52.32
- Support Level
- HUBS $375.01
- PODD $290.16
- Resistance Level
- HUBS $497.96
- PODD $335.00
- Average True Range (ATR)
- HUBS 15.98
- PODD 10.92
- MACD
- HUBS -8.87
- PODD 0.27
- Stochastic Oscillator
- HUBS 9.39
- PODD 71.75
About HUBS HubSpot Inc.
HubSpot provides a cloud-based marketing, sales, and customer service software platform referred to as the growth platform. The applications are available ala carte or packaged together. HubSpot's mission is to help companies grow better and has expanded from its initial focus on inbound marketing to embrace marketing, sales, and service more broadly. The company was founded in 2006, completed its initial public offering in 2014, and is headquartered in Cambridge, Massachusetts.
About PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.